Augmedix Inc (AUGX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
2.35 unch (unch) 10/01/24 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 2.35 unch (unch) -
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,171 | -24,449 | -17,464 | -15,604 | -18,498 |
| Depreciation Amortization | 1,098 | 856 | 691 | 867 | 949 |
| Accounts receivable | -2,398 | 786 | -4,431 | -402 | -126 |
| Accounts payable and accrued liabilities | -947 | 88 | 1,015 | -397 | 374 |
| Other Working Capital | -1,823 | 2,212 | -2,385 | -1,020 | 1,234 |
| Other Operating Activity | 7,800 | 3,734 | 3,982 | 2,157 | 1,422 |
| Operating Cash Flow | $-15,441 | $-16,773 | $-18,592 | $-14,399 | $-14,645 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,105 | -1,408 | -611 | -647 | -823 |
| Investing Cash Flow | $-3,105 | $-1,408 | $-611 | $-647 | $-823 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 5,000 | 15,000 | 15,000 | 2,680 | 3,304 |
| Debt Repayment | N/A | -16,125 | -12,966 | N/A | -1,358 |
| Common Stock Issued | 39,090 | 30 | 40,156 | 27,497 | 4 |
| Other Financing Activity | -720 | -142 | -4,363 | -3,760 | 15,219 |
| Financing Cash Flow | $43,370 | $-1,237 | $37,827 | $26,417 | $17,168 |
| Exchange Rate Effect | -470 | -181 | -10 | -1 | -10 |
| Beginning Cash Position | 21,988 | 41,587 | 22,973 | 11,603 | 9,915 |
| End Cash Position | 46,342 | 21,988 | 41,587 | 22,973 | 11,603 |
| Net Cash Flow | $24,354 | $-19,599 | $18,614 | $11,370 | $1,689 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,441 | -16,773 | -18,592 | -14,399 | -14,645 |
| Capital Expenditure | -3,105 | -1,408 | -611 | -647 | -823 |
| Free Cash Flow | -18,546 | -18,181 | -19,203 | -15,046 | -15,468 |